NPPA issued a notification regarding the

Dec 17, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00

Industry Specific Compliance The National Pharmaceutical Pricing Authority (NPPA) on December 16, 2024, issued a notification regarding the fixation of the retail price of Montelukast Sodium IP eq to Montelukast 4mg + Bilastine IP 10mg.

The following has been stated: -

•For each 5ml suspension contains: Montelukast Sodium IP eq to Montelukast 4mg + Bilastine IP 10mg for M/s Synokem Pharmaceuticals Ltd (Manufacturer) & M/s Intas Pharmaceuticals Ltd (Marketer) and the retail price is 1.69 (Rs.).

[Notification No. 19(4305)/2024/DP/NPPA/Div.III/9531/2024]

View Document 1